197 related articles for article (PubMed ID: 17095575)
1. 1Alpha,25(OH)2D3-induced transrepression by vitamin D receptor through E-box-type elements in the human parathyroid hormone gene promoter.
Kim MS; Fujiki R; Murayama A; Kitagawa H; Yamaoka K; Yamamoto Y; Mihara M; Takeyama K; Kato S
Mol Endocrinol; 2007 Feb; 21(2):334-42. PubMed ID: 17095575
[TBL] [Abstract][Full Text] [Related]
2. Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching.
Murayama A; Kim MS; Yanagisawa J; Takeyama K; Kato S
EMBO J; 2004 Apr; 23(7):1598-608. PubMed ID: 15934135
[TBL] [Abstract][Full Text] [Related]
3. Transrepression of the estrogen receptor promoter by calcitriol in human breast cancer cells via two negative vitamin D response elements.
Swami S; Krishnan AV; Peng L; Lundqvist J; Feldman D
Endocr Relat Cancer; 2013 Aug; 20(4):565-77. PubMed ID: 23744764
[TBL] [Abstract][Full Text] [Related]
4. Liganded Vitamin D Receptor Through Its Interacting Repressor Inhibits the Expression of Type I Collagen α1.
Wan LY; Zhang YQ; Li JM; Tang HQ; Chen MD; Ni YR; Huang H; Liu CB; Wu JF
DNA Cell Biol; 2016 Sep; 35(9):498-505. PubMed ID: 27351590
[TBL] [Abstract][Full Text] [Related]
5. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D receptor binding to the negative human parathyroid hormone vitamin D response element does not require the retinoid x receptor.
Mackey SL; Heymont JL; Kronenberg HM; Demay MB
Mol Endocrinol; 1996 Mar; 10(3):298-305. PubMed ID: 8833658
[TBL] [Abstract][Full Text] [Related]
7. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes.
Ellison TI; Eckert RL; MacDonald PN
J Biol Chem; 2007 Apr; 282(15):10953-62. PubMed ID: 17310066
[TBL] [Abstract][Full Text] [Related]
8. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
Harant H; Spinner D; Reddy GS; Lindley IJ
J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570
[TBL] [Abstract][Full Text] [Related]
9. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3.
Zella LA; Kim S; Shevde NK; Pike JW
Mol Endocrinol; 2006 Jun; 20(6):1231-47. PubMed ID: 16497728
[TBL] [Abstract][Full Text] [Related]
10. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
11. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor interactions with the rat parathyroid hormone gene: synergistic effects between two negative vitamin D response elements.
Russell J; Ashok S; Koszewski NJ
J Bone Miner Res; 1999 Nov; 14(11):1828-37. PubMed ID: 10571682
[TBL] [Abstract][Full Text] [Related]
13. Structure-function relationship of human parathyroid hormone in the regulation of vitamin D receptor expression in osteoblast-like cells (ROS 17/2.8).
Sriussadaporn S; Wong MS; Whitfield JF; Tembe V; Favus MJ
Endocrinology; 1995 Sep; 136(9):3735-42. PubMed ID: 7649079
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the human cyclin C gene via multiple vitamin D3-responsive regions in its promoter.
Sinkkonen L; Malinen M; Saavalainen K; Väisänen S; Carlberg C
Nucleic Acids Res; 2005; 33(8):2440-51. PubMed ID: 15863722
[TBL] [Abstract][Full Text] [Related]
15. Regulation of renal parathyroid hormone receptor expression by 1, 25-dihydroxyvitamin D3 and retinoic acid.
Sneddon WB; Barry EL; Coutermarsh BA; Gesek FA; Liu F; Friedman PA
Cell Physiol Biochem; 1998; 8(5):261-77. PubMed ID: 9792954
[TBL] [Abstract][Full Text] [Related]
16. An essential role of the CAAT/enhancer binding protein-alpha in the vitamin D-induced expression of the human steroid/bile acid-sulfotransferase (SULT2A1).
Song CS; Echchgadda I; Seo YK; Oh T; Kim S; Kim SA; Cho S; Shi L; Chatterjee B
Mol Endocrinol; 2006 Apr; 20(4):795-808. PubMed ID: 16357103
[TBL] [Abstract][Full Text] [Related]
17. Relationship of structure and function of DNA-binding domain in vitamin D receptor.
Wan LY; Zhang YQ; Chen MD; Liu CB; Wu JF
Molecules; 2015 Jul; 20(7):12389-99. PubMed ID: 26198224
[TBL] [Abstract][Full Text] [Related]
18. DNA bending is induced by binding of vitamin D receptor-retinoid X receptor heterodimers to vitamin D response elements.
Kimmel-Jehan C; Darwish HM; Strugnell SA; Jehan F; Wiefling B; DeLuca HF
J Cell Biochem; 1999 Aug; 74(2):220-8. PubMed ID: 10404392
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer cell type-specific involvement of the VDR and RXR in regulation of the human PTHrP gene via a negative VDRE.
Sepulveda VA; Weigel NL; Falzon M
Steroids; 2006 Feb; 71(2):102-15. PubMed ID: 16243370
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor.
Saramäki A; Banwell CM; Campbell MJ; Carlberg C
Nucleic Acids Res; 2006; 34(2):543-54. PubMed ID: 16434701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
